FDA Finds E. Coli in Prepackaged Nestle Toll Hose REfrigerated Cookie Dough
June 30, 2009
FDA CONFIRMS E. COLI O157:H7 IN PREPACKAGED NESTLÉ TOLL HOUSE REFRIGERATED COOKIE DOUGH
Washington DC (RPRN) 6/30/2009--The U.S. Food and Drug Administration announced on June 26 that it has found E. coli O157:H7 (a bacterium that can cause serious food borne illness) in a sample of prepackaged Nestlé Toll House refrigerated cookie dough currently under recall by the manufacturer and marketer, Nestlé USA. The contaminated sample was collected at Nestlé’s facility in Danville, Va. on June 25, 2009.
On June 19, the FDA and the U.S. Centers for Disease Control and Prevention warned consumers not to eat any varieties of prepackaged Nestlé Toll House refrigerated cookie dough due to the risk of contamination with E. coli O157:H7. The warning was based on an epidemiological study conducted by the CDC and several state and local health departments. As of Thursday, June 25, the CDC reports that 69 persons from 29 states have been infected with the outbreak strain. Thirty-four persons have been hospitalized, nine with a severe complication called hemolytic uremic syndrome. No one has died.
Further laboratory testing is needed to conclusively link the E. coli strain found in the product to the same strain that is causing the outbreak.
Nestlé USA has fully cooperated with the FDA and CDC investigation and has recalled all of its prepackaged Nestlé Toll House refrigerated cookie dough products.
For answers to consumer questions about this recall and warning, go to: http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm168346.htm.
For more information about E. coli, visit the CDC Web site at: http://www.cdc.gov/ecoli/.
Consumers who have additional questions about these products should contact Nestlé USA consumer services at 1-800-559-5025 and/or visit its Web site at www.verybestbaking.com.exit icon
For a complete listing of Nestlé USA recalled products go to:
http://www.Nestlé usa.com/PubNews/PressReleaseLibraryDetails.aspx?id=133CC131-A79F-4E84-9C43-C9F99FE5BC99.exit icon
Media Inquiries: Stephanie Kwisnek, 301-796-4737, Stephanie.Kwisnek@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
About the author: RushPR News is a social media newswire service created to help you with content creation and distribution to news outlets and social media networks. RushPRnews can also assist you with your web strategies with experts advices and strategies at an affordable cost. Write us at news@rushprnews.com
Filed Under:
Health and Fitness, Lifestyle, PRESS RELEASE, FDA- Pharmaceutical news, Article-byline, U.S.A. Government
RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com
Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.
Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.
Rush PR News is not the contact for material published.